A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even recurring cases of these cancers.
The vaccine is currently being tested, but has already had a success in their first human participant who was diagnosed with stage 0 breast cancer. The vaccine is used to trigger the patient’s immune system, which “crowds” and eliminates the cancer cells.
This is an incredible development in the research of breast cancer and related cancer treatments, and something American Nurse is excited to report on.
Please read more about this story here.
